Welcome to our dedicated page for Acadia Healthcar news (Ticker: ACHC), a resource for investors and traders seeking the latest updates and insights on Acadia Healthcar stock.
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a behavioral healthcare company that operates a large network of inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, comprehensive treatment centers and outpatient clinics across the United States and Puerto Rico. This news page aggregates company-specific updates and disclosures that help investors and observers follow developments in Acadia’s behavioral healthcare operations and corporate activities.
News related to ACHC often includes quarterly earnings releases, updates to financial guidance, and details on revenue performance by service type, such as acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers and residential treatment centers. The company also issues news about capital expenditure plans, bed additions, and development activity, including the opening of new hospitals, expansions of existing facilities and the addition of new comprehensive treatment centers.
Acadia’s news flow features announcements about participation in healthcare and investor conferences hosted by firms such as J.P. Morgan, UBS and Jefferies, where members of senior management discuss strategy, capital allocation and operating performance. Press releases may also cover executive leadership changes, including appointments and transitions in key roles like the Chief Financial Officer and Chief Operating Officer, as well as statements from the company regarding its approach to shareholder value and governance.
Other notable news items can include updates on professional and general liability reserves, securities litigation settlements, and responses to public letters from shareholders who comment on strategy and governance. By reviewing the ACHC news feed on this page, users can monitor Acadia’s reported operating trends, strategic priorities, capital plans and governance developments over time.
Acadia Healthcare (NASDAQ: ACHC) has scheduled its second quarter 2025 earnings release for Tuesday, August 5, 2025, after market close. The company will host a conference call with institutional investors and analysts on Wednesday, August 6, 2025, at 9:00 a.m. ET.
The conference call will be accessible via live webcast on the company's website at www.acadiahealthcare.com in the "Investors" section, with the recording remaining available for 30 days following the event.
Acadia Healthcare (NASDAQ: ACHC) has announced its participation in the BofA Securities 2025 Health Care Conference, scheduled for May 13-15, 2025, in Las Vegas, Nevada. The company will deliver a presentation on Wednesday, May 14th, 2025, at 1:20 p.m. Central Time (11:20 a.m. Pacific Time). Investors can access the live webcast of the presentation through the "Investors" section of Acadia's website at www.acadiahealthcare.com. A replay of the presentation will remain available on the company's website for 30 days following the event.
[ { "q": "When is Acadia Healthcare (ACHC) presenting at the BofA Securities Health Care Conference 2025?", "a": "Acadia Healthcare will present on Wednesday, May 14th, 2025, at 1:20 p.m. Central Time (11:20 a.m. Pacific Time)." }, { "q": "How can I watch Acadia Healthcare's presentation at the BofA Securities conference?", "a": "The presentation can be accessed via live webcast through the 'Investors' section of Acadia's website (www.acadiahealthcare.com)." }, { "q": "How long will Acadia Healthcare's BofA Securities conference presentation replay be available?", "a": "The presentation replay will be available on Acadia Healthcare's website for 30 days after the event." }, { "q": "Where is the BofA Securities 2025 Health Care Conference being held?", "a": "The conference is being held in Las Vegas, Nevada." } ]Acadia Healthcare (NASDAQ: ACHC) has scheduled its first quarter 2025 earnings release for Monday, May 12, 2025, after market close. The company will host a conference call with institutional investors and analysts on Tuesday, May 13, 2025, at 8:30 a.m. ET.
Additionally, the company announced that CFO Heather Dixon will take a brief medical leave starting April 18, 2025, for a planned medical procedure. During her absence, Acadia's senior finance leadership team and executive management will manage her responsibilities. Dixon is expected to participate in the May 13 earnings call.
Acadia Healthcare (NASDAQ: ACHC) has announced the pricing of its private offering of $550 million in senior notes due 2033, representing a $50 million increase from its previous announcement. The notes will bear interest at 7.375% per year, payable semi-annually on March 15 and September 15, starting September 15, 2025.
The offering is expected to close on March 10, 2025, subject to customary conditions. The notes were offered at 100.000% of the principal amount and will mature on March 15, 2033. Acadia plans to use the proceeds to prepay outstanding borrowings under its existing senior secured revolving line of credit.
The notes are being offered exclusively to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S of the Securities Act.
Acadia Healthcare (NASDAQ: ACHC) has announced a private offering of $500 million in senior notes due 2033. The company plans to use the proceeds to prepay a portion of its outstanding borrowings under its existing senior secured revolving line of credit.
The notes will only be offered to 'qualified institutional buyers' under Rule 144A of the Securities Act and non-U.S. persons under Regulation S. The notes have not been registered under the Securities Act of 1933 and cannot be offered or sold in the United States except under applicable exemptions.
Acadia Healthcare (NASDAQ: ACHC) reported strong Q4 2024 results with revenue of $774.2 million, up 4.2% year-over-year. Same facility revenue increased 4.7%, driven by a 3.2% rise in patient days and 1.4% growth in revenue per patient day.
The company achieved net income of $32.6 million ($0.35 per diluted share) and adjusted income of $59.2 million ($0.64 per diluted share). Q4 Adjusted EBITDA was $153.1 million, including a $14.3 million professional liability reserve adjustment and $5.0 million impact from facility closure.
Notable developments include adding 577 newly licensed beds in Q4, completing construction of approximately 1,300 beds in 2024, and announcing a new $300 million share repurchase authorization. The company expanded its CTC network to 163 centers across 33 states, treating over 72,000 patients daily.
Acadia Healthcare (NASDAQ: ACHC) has announced its participation in three major investor conferences during March 2025:
1. Raymond James 46th Annual Institutional Investors Conference in Orlando, Florida (March 2-5), presenting on March 4 at 8:05 a.m. ET
2. Leerink Partners 2025 Global Healthcare Conference in Miami, Florida (March 10-12), presenting on March 11 at 2:20 p.m. ET
3. Barclays 27th Annual Global Healthcare Conference in Miami, Florida (March 11-13), presenting on March 12 at 9:30 a.m. ET
All presentations will be available via live webcast on Acadia Healthcare's website through the Investors section. Replays will remain accessible for 30 days following the events.
Acadia Healthcare (NASDAQ: ACHC) has announced it will release its fourth quarter and year-end 2024 financial results on Thursday, February 27, 2025, after market close. The company will host a conference call with institutional investors and analysts at 9:00 a.m. ET on Friday, February 28, 2025. A live webcast of the conference call will be accessible through the 'Investors' section of Acadia's website and will remain available for 30 days.
Acadia Healthcare (NASDAQ: ACHC) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference, scheduled for January 13-16, 2025, in San Francisco, California. The company will deliver a presentation that will be available via webcast on Tuesday, January 14, 2025, at 1:30 p.m. Pacific Time/3:30 p.m. Central Time.
Investors and interested parties can access the live webcast through the 'Investors' section of Acadia Healthcare's website (www.acadiahealthcare.com). A replay of the presentation will remain accessible on the company's website for 30 days following the event.